
Loading, please wait...

Loading, please wait...

Medication reconciliation is a critical process for ensuring patient safety during transitions of care. However, the manual effort required often leads to inconsistencies and potential errors. **AI in medication reconciliation** is emerging as a transformative tool to enhance the accuracy of medication histories. A recent scoping review analyzed the current landscape of AI applications in this field to determine their effectiveness.
The review identified three primary tasks: creating medication histories, identifying discrepancies, and resolving them. Most research focuses on the first stage. Specifically, 97.9% of the studies automated information acquisition. Researchers primarily used machine learning to extract data from clinical notes. Additionally, some studies utilized pill images to identify medications through convolutional neural networks. These advancements show how AI can streamline the heavy workload of data collection.
Despite these technological advancements, significant gaps remain. Only a tiny fraction of studies addressed discrepancy identification. Furthermore, the automation of discrepancy resolution is still largely unexplored in current literature. Most models currently exist as proofs-of-concept rather than clinical tools. Therefore, moving from model development to real-world usability is essential for clinical practice. This evolution will require more focus on the integration of these tools into existing workflows.
Healthcare providers must address data incompleteness to improve these systems. Because many sources lack structured data, AI models often struggle with perfect accuracy. Consequently, future efforts should prioritize discrepancy resolution and real-world implementation. This shift will ensure that AI-driven tools provide meaningful support to clinicians and patients alike. By overcoming infrastructural barriers, the medical community can move toward a safer, automated reconciliation process.
The core tasks include creating a best possible medication history, identifying discrepancies between different medication lists, and resolving those discrepancies to ensure patient safety.
Most AI applications focus on extracting medication data from free-text clinical notes using machine learning or identifying medications through pill images using neural networks.
Primary barriers include data incompleteness in electronic health records and a lack of studies focused on real-world usability and the resolution of medication discrepancies.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Tabja Bortesi JP et al. AI-Based Automation for Medication Reconciliation: Scoping Review. J Med Internet Res. 2026 May 11. doi: 10.2196/86760. PMID: 42114154.
World Health Organization. Medication Safety in Transitions of Care. Technical Report. 2019.
Institute for Safe Medication Practices. Medication Reconciliation: The Next Generation of Patient Safety. 2023.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A comprehensive scoping review examines the role of AI in automating medication reconciliation tasks and identifies gaps in discrepancy resolution....
5 months ago

Following Nigeria's first recorded Ebola case linked to regional travel, the Africa CDC has convened an emergency ministerial summit. This alert underscores critical clinical priorities for healthcare professionals, including differentiating early viral infection from malaria, implementing barrier nursing, and triage.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today